Myriam Soto-Gordoa1, Arantzazu Arrospide2, Ander Zapiain3, Arantza Aiarza3, Luis Carlos Abecia4, Javier Mar5. 1. Unidad de Investigación AP-OSI, Hospital Alto Deba, Arrasate-Mondragón (Vizcaya), España. Electronic address: myriam.sotoruizdegordoa@osakidetza.net. 2. Unidad de Investigación AP-OSI, Hospital Alto Deba, Arrasate-Mondragón (Vizcaya), España. 3. Servicio de Atención a la Dependencia y Discapacidad, Diputación de Gipuzkoa, Donostia-San Sebastián (Guipúzcoa), España. 4. Departamento de Medicina Preventiva y Salud Pública, Universidad del País-Vasco-Euskal Herriko Unibertsitatea (UPV-EHU), Vitoria-Gasteiz (Álava), España. 5. Unidad de Investigación AP-OSI, Hospital Alto Deba, Arrasate-Mondragón (Vizcaya), España; Unidad de Gestión Sanitaria, Hospital Alto Deba, Arrasate-Mondragón (Vizcaya), España; Red de Investigación en Servicios de Salud y Enfermedades Crónicas (REDISSEC), España.
Abstract
AIM: To calculate the formal cost of social care for people with Alzheimer disease according to the implementation of the dependency law in Gipuzkoa (Spain). METHOD: A retrospective observational study was carried out of the database of the Dependency Care Services of Gipuzkoa from 2007 to 2012, using a prevalence-based bottom-up approach. RESULTS: The average annual formal cost per person was €11,730. The annual population cost was €34.7 million, representing 19% of the annual expenditure corresponding to the dependency law and 29% of the total cost of Alzheimer disease. CONCLUSIONS: Despite the implementation of the new law, most of the burden of the disease is bourne by the family.
AIM: To calculate the formal cost of social care for people with Alzheimer disease according to the implementation of the dependency law in Gipuzkoa (Spain). METHOD: A retrospective observational study was carried out of the database of the Dependency Care Services of Gipuzkoa from 2007 to 2012, using a prevalence-based bottom-up approach. RESULTS: The average annual formal cost per person was €11,730. The annual population cost was €34.7 million, representing 19% of the annual expenditure corresponding to the dependency law and 29% of the total cost of Alzheimer disease. CONCLUSIONS: Despite the implementation of the new law, most of the burden of the disease is bourne by the family.
Authors: Javier Mar; Ania Gorostiza; Oliver Ibarrondo; Igor Larrañaga; Arantzazu Arrospide; Pablo Martinez-Lage; Myriam Soto-Gordoa Journal: Alzheimers Res Ther Date: 2020-12-11 Impact factor: 6.982